{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:54:21Z","timestamp":1716922461192},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Serious cutaneous adverse drug reactions [i.e., SJS\/TEN with severe ocular complications (SOC)] associated with cold medicine (CM) were reported in several studies. To assess the risks of CM-induced SJS\/TEN with SOC, systematic review and meta-analysis were employed. Studies investigating associations between <jats:italic>HLA<\/jats:italic> genotypes and CM-induced SJS\/TEN with SOC were systematically searched in PubMed, Scopus and the Cochrane Library. Overall odds ratios (ORs) with 95% CIs were calculated using a random-effects model to determine these associations. An initial search of the databases identified 24,011 articles, of which 6 studies met the inclusion criteria. In total from all studies, associations between 81 different HLA genotypes and CM-induced SJS\/TEN with SOC (i.e., 22 different <jats:italic>HLA-A<\/jats:italic> genotypes, 40 different <jats:italic>HLA-B<\/jats:italic> genotypes and 19 different <jats:italic>HLA-C<\/jats:italic> genotypes) were investigated. Risk factors to develop SJS\/TEN with SOC in patients who used CM were identified from our meta-analysis. <jats:italic>HLA-A*0206<\/jats:italic> (OR\u2009=\u20093.90; 95% CI\u2009=\u20091.96\u20137.77)<jats:italic>, HLA-A*3303<\/jats:italic> (OR\u2009=\u20092.28; 95% CI\u2009=\u20091.31\u20133.97)<jats:italic>, HLA-B*4403<\/jats:italic> (OR\u2009=\u20093.27; 95% CI\u2009=\u20091.52\u20137.03) and <jats:italic>HLA-C*0501<\/jats:italic> (OR\u2009=\u20092.55; 95% CI\u2009=\u20091.19\u20135.44) were associated with CM-induced SJS\/TEN with SOC. With our results demonstrating a significant association between using of CMs and the severe ADR, a genetic testing can be helpful. However, the CMs are commonly used as an over-the-counter drug in practically almost of people in populations worldwide, the genetic screening prior to use of the CMs might not be cost-effective. Nonetheless, for people with a family history of developing the ADRs with a possible involvement of CMs, a genetic screening may be beneficial.<\/jats:p>","DOI":"10.1038\/s41598-020-67610-5","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T10:03:01Z","timestamp":1593424981000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["HLA genotypes and cold medicine-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"10","author":[{"given":"Wimonchat","family":"Tangamornsuksan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirikan","family":"Chanprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phenphechaya","family":"Nadee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saowalak","family":"Rungruang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natnaree","family":"Meesilsat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manupat","family":"Lohitnavy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"67610_CR1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau, J. C. & Stern, R. S. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331, 1272\u20131285. https:\/\/doi.org\/10.1056\/NEJM199411103311906 (1994).","journal-title":"N. Engl. J. Med."},{"key":"67610_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr, T. & French, L. E. Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. Orphanet. J. Rare. Dis. 5, 39. https:\/\/doi.org\/10.1186\/1750-1172-5-39 (2010).","journal-title":"Orphanet. J. Rare. Dis."},{"key":"67610_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","volume":"54","author":"M Lerch","year":"2018","unstructured":"Lerch, M., Mainetti, C., Terziroli Beretta-Piccoli, B. & Harr, T. Current perspectives on Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Clin. Rev. Allergy Immunol. 54, 147\u2013176. https:\/\/doi.org\/10.1007\/s12016-017-8654-z (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"67610_CR4","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1001\/jamadermatol.2017.3957","volume":"153","author":"EN Ergen","year":"2017","unstructured":"Ergen, E. N. & Hughey, L. C. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. JAMA Dermatol. 153, 1344. https:\/\/doi.org\/10.1001\/jamadermatol.2017.3957 (2017).","journal-title":"JAMA Dermatol."},{"key":"67610_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14409","author":"AJ Zhang","year":"2019","unstructured":"Zhang, A. J., Nygaard, R. M., Endorf, F. W. & Hylwa, S. A. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: retrospective review of 10-year experience. Int. J. Dermatol. https:\/\/doi.org\/10.1111\/ijd.14409 (2019).","journal-title":"Int. J. Dermatol."},{"key":"67610_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14493","author":"OY Carrasquillo","year":"2019","unstructured":"Carrasquillo, O. Y., Santiago-Vazquez, M., Cardona, R., Cruz-Manzano, M. & Figueroa, L. D. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study. Int. J. Dermatol. https:\/\/doi.org\/10.1111\/ijd.14493 (2019).","journal-title":"Int. J. Dermatol."},{"key":"67610_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","volume":"14","author":"S Kohanim","year":"2016","unstructured":"Kohanim, S. et al. Acute and chronic ophthalmic involvement in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis\u2014a comprehensive review and guide to therapy II. Ophthalmic disease. Ocul. Surf. 14, 168\u2013188. https:\/\/doi.org\/10.1016\/j.jtos.2016.02.001 (2016).","journal-title":"Ocul. Surf."},{"key":"67610_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono, C. et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens\u2013Johnson syndrome. Ophthalmology 114, 1294\u20131302. https:\/\/doi.org\/10.1016\/j.ophtha.2006.10.029 (2007).","journal-title":"Ophthalmology"},{"key":"67610_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang, Y. S. et al. Erythema multiforme, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26, 123\u2013129. https:\/\/doi.org\/10.1097\/ICO.0b013e31802eb264 (2007).","journal-title":"Cornea"},{"key":"67610_CR10","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau, J. C. et al. Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis. N. Engl. J. Med. 333, 1600\u20131607. https:\/\/doi.org\/10.1056\/NEJM199512143332404 (1995).","journal-title":"N. Engl. J. Med."},{"key":"67610_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt, M. The current understanding of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Expert Rev. Clin. Immunol. 7, 803\u2013813. https:\/\/doi.org\/10.1586\/eci.11.66 (2011).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"67610_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0095-4543(05)70355-9","volume":"23","author":"GL Kirkpatrick","year":"1996","unstructured":"Kirkpatrick, G. L. The common cold. Prim. Care 23, 657\u2013675 (1996).","journal-title":"Prim. Care"},{"key":"67610_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tjo.2016.06.001","volume":"6","author":"M Ueta","year":"2016","unstructured":"Ueta, M. Cold medicine-related Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis with severe ocular complications-phenotypes and genetic predispositions. Taiwan J. Ophthalmol. 6, 108\u2013118. https:\/\/doi.org\/10.1016\/j.tjo.2016.06.001 (2016).","journal-title":"Taiwan J. Ophthalmol."},{"key":"67610_CR14","doi-asserted-by":"publisher","first-page":"des183","DOI":"10.1167\/iovs.17-23537","volume":"59","author":"M Ueta","year":"2018","unstructured":"Ueta, M. Results of detailed investigations into Stevens\u2013Johnson syndrome with severe ocular complications. Invest. Ophthalmol. Vis. Sci. 59, des183\u2013des191. https:\/\/doi.org\/10.1167\/iovs.17-23537 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"67610_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","volume":"149","author":"W Tangamornsuksan","year":"2013","unstructured":"Tangamornsuksan, W., Chaiyakunapruk, N., Somkrua, R., Lohitnavy, M. & Tassaneeyakul, W. Relationship between the HLA-B*1502 Allele and Carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 149, 1025\u20131032 (2013).","journal-title":"JAMA Dermatol."},{"key":"67610_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.18433\/J39S3T","volume":"18","author":"W Tangamornsuksan","year":"2015","unstructured":"Tangamornsuksan, W. et al. Association of HLA-B*5701 genotypes and abacavir-induced hypersensitivity reaction: a systematic review and meta-analysis. J. Pharm. Pharm. Sci. 18, 68\u201376 (2015).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"67610_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamadermatol.2017.6484","volume":"154","author":"W Tangamornsuksan","year":"2018","unstructured":"Tangamornsuksan, W. & Lohitnavy, M. Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. JAMA Dermatol. 154, 441\u2013446. https:\/\/doi.org\/10.1001\/jamadermatol.2017.6484 (2018).","journal-title":"JAMA Dermatol."},{"key":"67610_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/tan.13530","volume":"93","author":"KA Mullan","year":"2019","unstructured":"Mullan, K. A. et al. HLA-associated antiepileptic drug-induced cutaneous adverse reactions. HLA 93, 417\u2013435. https:\/\/doi.org\/10.1111\/tan.13530 (2019).","journal-title":"HLA"},{"key":"67610_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18433\/j36s7d","volume":"21","author":"W Tangamornsuksan","year":"2018","unstructured":"Tangamornsuksan, W., Scholfield, N. & Lohitnavy, M. Association between HLA genotypes and oxcarbazepine-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. J. Pharm. Pharm. Sci. 21, 1\u201318. https:\/\/doi.org\/10.18433\/j36s7d (2018).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"67610_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41397-018-0052-2","volume":"19","author":"W Tangamornsuksan","year":"2019","unstructured":"Tangamornsuksan, W. & Lohitnavy, M. Association between HLA-B*5901 and methazolamide-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: a systematic review and meta-analysis. Pharmacogenomics J. 19, 286\u2013294. https:\/\/doi.org\/10.1038\/s41397-018-0052-2 (2019).","journal-title":"Pharmacogenomics J."},{"key":"67610_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-019-0092-2","author":"W Tangamornsuksan","year":"2019","unstructured":"Tangamornsuksan, W., Kongkaew, C., Scholfield, C. N., Subongkot, S. & Lohitnavy, M. HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis. Pharmacogenomics J. https:\/\/doi.org\/10.1038\/s41397-019-0092-2 (2019).","journal-title":"Pharmacogenomics J."},{"key":"67610_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2217\/pme.10.46","volume":"7","author":"M Bharadwaj","year":"2010","unstructured":"Bharadwaj, M., Illing, P. & Kostenko, L. Personalized medicine for HLA-associated drug-hypersensitivity reactions. Pers. Med. 7, 495\u2013516. https:\/\/doi.org\/10.2217\/pme.10.46 (2010).","journal-title":"Pers. Med."},{"key":"67610_CR23","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1038\/srep04862","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens\u2013Johnson syndrome with severe mucosal involvement. Sci. Rep. 4, 4862. https:\/\/doi.org\/10.1038\/srep04862 (2014).","journal-title":"Sci. Rep."},{"key":"67610_CR24","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1038\/srep05981","volume":"4","author":"M Ueta","year":"2014","unstructured":"Ueta, M. et al. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens\u2013Johnson syndrome with severe ocular surface complications. Sci. Rep. 4, 5981. https:\/\/doi.org\/10.1038\/srep05981 (2014).","journal-title":"Sci. Rep."},{"key":"67610_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jclinepi.2005.01.001","volume":"58","author":"K Smits","year":"2005","unstructured":"Smits, K. et al. A review on the design and reporting of studies on drug-gene interaction. J. Clin. Epidemiol. 58, 651\u2013654 (2005).","journal-title":"J. Clin. Epidemiol."},{"key":"67610_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/430507","volume":"76","author":"JK Wittke-Thompson","year":"2005","unstructured":"Wittke-Thompson, J. K., Pluzhnikov, A. & Cox, N. J. Rational inferences about departures from Hardy\u2013Weinberg equilibrium. Am. J. Hum. Genet. 76, 967\u2013986. https:\/\/doi.org\/10.1086\/430507 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"67610_CR27","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrg1916","volume":"7","author":"DJ Balding","year":"2006","unstructured":"Balding, D. J. A tutorial on statistical methods for population association studies. Nat. Rev. Genet. 7, 781\u2013791. https:\/\/doi.org\/10.1038\/nrg1916 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"67610_CR28","unstructured":"28Wells, G. et al. The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (2011)."},{"key":"67610_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177\u2013188 (1986).","journal-title":"Control. Clin. Trials"},{"key":"67610_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"J Higgins","year":"2002","unstructured":"Higgins, J. & Thompson, S. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539\u20131558 (2002).","journal-title":"Stat. Med."},{"key":"67610_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins, J., Thompson, S., Deeks, J. & Altman, D. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003).","journal-title":"BMJ"},{"key":"67610_CR32","doi-asserted-by":"publisher","first-page":"15023","DOI":"10.1038\/hgv.2015.23","volume":"2","author":"M Ueta","year":"2015","unstructured":"Ueta, M. et al. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens\u2013Johnson syndrome with severe ocular complications. Hum. Genome. Var. 2, 15023. https:\/\/doi.org\/10.1038\/hgv.2015.23 (2015).","journal-title":"Hum. Genome. Var."},{"key":"67610_CR33","doi-asserted-by":"publisher","first-page":"15960","DOI":"10.1038\/s41598-017-15965-7","volume":"7","author":"C Kannabiran","year":"2017","unstructured":"Kannabiran, C. et al. Association of human Leukocyte antigen class 1 genes with Stevens\u2013Johnson syndrome with severe ocular complications in an Indian population. Sci. Rep. 7, 15960. https:\/\/doi.org\/10.1038\/s41598-017-15965-7 (2017).","journal-title":"Sci. Rep."},{"key":"67610_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaophthalmol.2017.0074","volume":"135","author":"TH Wakamatsu","year":"2017","unstructured":"Wakamatsu, T. H. et al. Human leukocyte antigen class I genes associated with Stevens\u2013Johnson syndrome and severe ocular complications following use of cold medicine in a Brazilian population. JAMA Ophthalmol. 135, 355\u2013360. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.0074 (2017).","journal-title":"JAMA Ophthalmol."},{"key":"67610_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/bjophthalmol-2017-311823","volume":"102","author":"P Jongkhajornpong","year":"2018","unstructured":"Jongkhajornpong, P. et al. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens\u2013Johnson syndrome with severe ocular complications in Thailand. Br. J. Ophthalmol. 102, 1303\u20131307. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311823 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"67610_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/bjophthalmol-2018-313263","volume":"103","author":"I Jun","year":"2019","unstructured":"Jun, I. et al. Association of human antigen class I genes with cold medicine-related Stevens\u2013Johnson syndrome with severe ocular complications in a Korean population. Br. J. Ophthalmol. 103, 573\u2013576. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313263 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"67610_CR37","doi-asserted-by":"publisher","first-page":"D784","DOI":"10.1093\/nar\/gku1166","volume":"43","author":"FF Gonzalez-Galarza","year":"2015","unstructured":"Gonzalez-Galarza, F. F. et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 43, D784\u2013D788. https:\/\/doi.org\/10.1093\/nar\/gku1166 (2015).","journal-title":"Nucleic Acids Res."},{"key":"67610_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13321-017-0202-6","volume":"9","author":"G Van Den Driessche","year":"2017","unstructured":"Van Den Driessche, G. & Fourches, D. Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study. J. Cheminform. 9, 13. https:\/\/doi.org\/10.1186\/s13321-017-0202-6 (2017).","journal-title":"J. Cheminform."},{"key":"67610_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.18433\/J38G7X","volume":"19","author":"LK Teh","year":"2016","unstructured":"Teh, L. K. et al. Coupling genotyping and computational modeling in prediction of anti-epileptic drugs that cause Stevens Johnson syndrome and toxic epidermal necrolysis for carrier of HLA-B*15:02. J. Pharm. Pharm. Sci. 19, 147\u2013160. https:\/\/doi.org\/10.18433\/J38G7X (2016).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"67610_CR40","doi-asserted-by":"publisher","first-page":"514068","DOI":"10.1155\/2013\/514068","volume":"2013","author":"H Isogai","year":"2013","unstructured":"Isogai, H. et al. In silico risk assessment of HLA-A*02:06-associated Stevens\u2013Johnson syndrome and toxic epidermal necrolysis caused by cold medicine ingredients. J. Toxicol. 2013, 514068. https:\/\/doi.org\/10.1155\/2013\/514068 (2013).","journal-title":"J. Toxicol."},{"issue":"Suppl 11","key":"67610_CR41","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/ico.0000000000000605","volume":"34","author":"M Ueta","year":"2015","unstructured":"Ueta, M. Genetic predisposition to Stevens\u2013Johnson syndrome with severe ocular surface complications. Cornea 34(Suppl 11), S158-165. https:\/\/doi.org\/10.1097\/ico.0000000000000605 (2015).","journal-title":"Cornea"},{"key":"67610_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jaci.2008.09.044","volume":"123","author":"M Ueta","year":"2009","unstructured":"Ueta, M., Matsuoka, T., Narumiya, S. & Kinoshita, S. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J. Allergy Clin. Immunol. 123, 466\u2013471. https:\/\/doi.org\/10.1016\/j.jaci.2008.09.044 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"67610_CR43","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cll.2018.08.002","volume":"38","author":"RJ Schutte","year":"2018","unstructured":"Schutte, R. J., Sun, Y., Li, D., Zhang, F. & Ostrov, D. A. Human leukocyte antigen associations in drug hypersensitivity reactions. Clin. Lab. Med. 38, 669\u2013677. https:\/\/doi.org\/10.1016\/j.cll.2018.08.002 (2018).","journal-title":"Clin. Lab. Med."},{"key":"67610_CR44","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00251-017-1007-5","volume":"69","author":"PT Illing","year":"2017","unstructured":"Illing, P. T., Purcell, A. W. & McCluskey, J. The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Immunogenetics 69, 617\u2013630. https:\/\/doi.org\/10.1007\/s00251-017-1007-5 (2017).","journal-title":"Immunogenetics"},{"key":"67610_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","volume":"6","author":"KD White","year":"2018","unstructured":"White, K. D. et al. SJS\/TEN 2017: building multidisciplinary networks to drive science and translation. J Allergy Clin Immunol 6, 38\u201369. https:\/\/doi.org\/10.1016\/j.jaip.2017.11.023 (2018).","journal-title":"J Allergy Clin Immunol"},{"key":"67610_CR46","first-page":"550","volume":"14","author":"M Ueta","year":"2008","unstructured":"Ueta, M. et al. HLA class I and II gene polymorphisms in Stevens\u2013Johnson syndrome with ocular complications in Japanese. Mol. Vis. 14, 550\u2013555 (2008).","journal-title":"Mol. Vis."},{"key":"67610_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin, S. et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme. Arch Dermatol 129, 92\u201396 (1993).","journal-title":"Arch Dermatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67610-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:56:50Z","timestamp":1670331410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-67610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["67610"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-67610-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10589"}}